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Tumour-stage mycosis
fungoides regressing with milia
and pustules after total skin
electron beam therapy
Editor
A healthy 66-year-old man presented with a three-year history
of a skin eruption, initially treated as psoriasis without response.
A biopsy was subsequently performed that was consistent with
mycosis fungoides (MF). This diagnosis was confirmed with a
positive T-cell gene rearrangement. The patient was referred to
our institution for management of tumour-stage MF. Due to
widespread skin involvement (approximately 80% body surface
area) and advanced stage, the patient was treated with total skin
electron therapy (TSET). He received 36Gy in 24 fractions of
1.5Gy each using the Stanford technique. This resulted in signifi-
cant clinical improvement.
Close skin examination 2 months after TSET revealed numer-
ous pustules in the area of the resolving tumours (Fig. 1). The
pustulosis was subsequently treated with tretinoin 0.025% oint-
ment with improvement.s
Milia formation following resolution of blistering diseases
such as bullous pemphigoid has been well described.1–3 A simi-
lar, although uncommon, phenomena consisting of milia forma-
tion has been documented in the recovery phase of MF treated
with topical nitrogen mustard with systemic acitretin 4 and pho-
tochemotherapy.5 To our knowledge, no reports have docu-
mented development of pustules in treatment of MF with TSET.
While the mechanism for the development of milia and pustules
in treated MF is not known, it has been hypothesized that
eccrine duct occlusion could be a contributing factor. This
occlusion may be a direct result of the regression of MF or from
occlusion with topical nitrogen mustard or systemic acitretin.4,5
There are also reports of acne vulgaris developing in areas of the
skin treated with radiation,6 although this is unlikely aetiologic
in our reported patient because the pustules were only evident in
areas of regressing tumour, sparing uninvolved skin.
It is important to recognize this uncommon entity for several
reasons. First, proper identification of this condition can elimi-
nate other differential considerations including miliaria rubra,
infection and pustular drug reaction. Milia and pustule forma-
tion, when appreciated at the onset of treatment, could also be
an early sign of regressing MF and therefore portend a favour-
able response to TSET. Finally, correct identification can lead to
proper treatment with topical tretinoin, which was of benefit to
our patient.
T. Puiu,1 D.A. Porto,2,3,* F. Siddiqui,2 H.W. Lim2
1University of Michigan Medical School, Ann Arbor, 48103 MI, USA,
2Department of Dermatology, Henry Ford Hospital, Detroit, 48202 MI,
USA, 3Harvard University Health Policy and Management, Boston, 02115
MA, USA
*Correspondence: D.A. Porto. E-mail: dporto@hsph.harvard.edu
References
1 Tsuruta D, Brzezinski P, Koga H, Ohata C, Furumura M, Hashimoto T.
Bullous pemphigoid with prominent milium formation. Acta Dermatoven-
erol Croat 2013; 21: 35–38.
2 Uchida S, Oiso N, Koga H et al. Refractory bullous pemphigoid leaving
numerous milia during recovery. J Dermatol 2014; 41: 1003–1005.
3 Hisa T, Goto Y, Taniguchi S, Nakanishi T, Kakudo K, Takigawa M. Post-
bullous milia. Australas J Dermatol 1996; 37: 153–154.
4 Mori T, Ohtsuka M, Hanami Y, Yamamoto T. Non-folliculotropic Milia in
a treated case of mycosis fungoides: a Rare Occurrence. Indian J Dermatol
2015; 60: 424.
5 Kalayciyan A, Oguz O, Demirkesen C, Serdaroglu S, Kotogyan A. Milia in
regressing plaques of mycosis fungoides: provoked by topical nitrogen
mustard or not? Int J Dermatol 2004; 43: 953–956.
6 Hubiche T, Sibaud V. Localized acne induced by radiation therapy. Derma-
tol Online J 2014; 20. pii: doj_21545.
DOI: 10.1111/jdv.14372
Guideline-based clinical decision
support in acne patients
receiving isotretinoin: improving
adherence and cost-
effectiveness
Editor
Clinical practice guidelines have proven to be a tool for con-
densing the overwhelming quantity of (new) medical knowl-
edge. However, there are barriers to implementation and
(a) (b)
Fig. 1 (a) The patient’s back 2 months after TSET for tumour-
stage MF. (b) Closer inspection reveals multiple milia and cystic
pustules within the resolving MF tumours and plaques.
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